Mattia Galli

Pubblicazioni

Titolo Pubblicato in Anno
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation–ACS/PCI Trials JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2020
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal INTERNATIONAL JOURNAL OF CARDIOLOGY. HEART & VASCULATURE 2020
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial TRIALS 2020
Telemedicine, artificial intelligence and humanisation of clinical pathways in heart failure management: back to the future and beyond CARDIAC FAILURE REVIEW 2020
Impact of coronary stenting on top of medical therapy on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials MINERVA CARDIOANGIOLOGICA 2020
Experience of remote cardiac care during the COVID-19 pandemic: the V-LAP (TM) device in advanced heart failure EUROPEAN JOURNAL OF HEART FAILURE 2020
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY 2020
Electronic cigarettes and Cardiovascular Risk: Caution Waiting for Evidence EUROPEAN CARDIOLOGY 2019
Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives INTERNATIONAL JOURNAL OF CARDIOLOGY 2019
Microvascular dysfunction in heart failure with preserved ejection fraction FRONTIERS IN PHYSIOLOGY 2019
Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY 2019
Dual Therapy with DOACs significantly increases the risk of Stent Thrombosis compared to Triple Therapy EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY 2019
Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability. An in vivo optical coherence tomography study JAMA CARDIOLOGY 2019
High-risk percutaneous coronary intervention: How to define it today? MINERVA CARDIOANGIOLOGICA 2018
Clinical potential relevance of metabolic properties of SGLT2 inhibitors in patients with heart failure EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma